Klaus Okkenhaug
Klaus Okkenhaug publishes mostly in Immunology, Molecular Biology and Oncology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and PI3K/AKT/mTOR signaling in cancer.
- World rank
- #46,347 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #3,708 of 367,258
- Works
- 192
- Citations
- 22k
- Citations per work
- 115.0
What does Klaus Okkenhaug research?
Klaus Okkenhaug's work is mostly in Immunology and Microbiology (42%), Biochemistry, Genetics and Molecular Biology (22%), Medicine (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences12364.0%
- Everything else4021.0%
- Health Sciences2915.0%
- Medicine2915.0%
- 1Immunology42% of their works
- 2Molecular Biology17% of their works
- 3Oncology10% of their works
- 4Genetics5% of their works
- 5Genetics3% of their works
- 6Cancer Research2% of their works
Research topics
Which keywords describe Klaus Okkenhaug's research?
The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, Foxp3, TGF-ß, mTOR, Signaling, Cancer Immunotherapy and Chronic Lymphocytic Leukemia.
- Immune Checkpoint Blockade
- Genetic Mutations
- CAR T Cells
- Dendritic Cells
- Chronic Lymphocytic Leukemia
- mTOR
- TGF-ß
- Natural Killer Cells
- NK Cell Recognition
- Foxp3
- Signaling
- Cancer Immunotherapy
- Genomic Aberrations
- Immunity
- Chimeric Antigen Receptor
- Primary Immunodeficiency
- PD-1 and PD-L1
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- NK Cell Recognition751 topic
- Natural Killer Cells751 topic
- Foxp3661 topic
- TGF-ß661 topic
- Signaling381 topic
- mTOR381 topic
- Cancer Immunotherapy372 topics
- Chronic Lymphocytic Leukemia251 topic
- Genomic Aberrations251 topic
- Dendritic Cells191 topic
- Immunity191 topic
- CAR T Cells181 topic
- Chimeric Antigen Receptor181 topic
- Genetic Mutations181 topic
- Primary Immunodeficiency181 topic
- Immune Checkpoint Blockade161 topic
- PD-1 and PD-L1161 topic
Where does Klaus Okkenhaug work?
Klaus Okkenhaug's main affiliation in the publication record is Babraham Institute, United Kingdom.
How many publications and citations does Klaus Okkenhaug have?
OpenAlex counts 192 works and 22,078 citations for Klaus Okkenhaug, an h-index of 67, ranking #46,347 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Klaus Okkenhaug. Posts are plain text and can be reported.